| 2025 | The Impact of Liraglutide on Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2025 | Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
| 2025 | Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV-Related Cirrhosis: A Landmark Analysis
| JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2025 | Temporal Dynamics and Treatment Outcomes of Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Multicenter Retrospective Study from South Korea
| GUT AND LIVER |
| 2025 | The Reply | GASTROENTEROLOGY |
| 2025 | Hepatocellular carcinoma risk stratification to identify patients suitable for intensive surveillance in viral hepatitis: the SELECT score
| EUROPEAN RADIOLOGY |
| 2025 | Diagnosing HCC with conventional and late portal venous phase MRI: intraindividual comparison of MRI with extracellular contrast agent | EUROPEAN RADIOLOGY |
| 2025 | Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria
| Journal of Liver Cancer(대한간암학회지) |
| 2025 | Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea
| Journal of Liver Cancer(대한간암학회지) |
| 2025 | Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B
| SCIENTIFIC REPORTS |
| 2025 | Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2025 | Roadmap for HCC Surveillance and Management in the Asia Pacific
| CANCERS |
| 2025 | Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab | HEPATOLOGY |
| 2025 | Noncontrast Magnetic Resonance Imaging vs Ultrasonography for Hepatocellular Carcinoma Surveillance: A Randomized, Single-Center Trial | GASTROENTEROLOGY |
| 2025 | Identification of new biomarkers of hepatic cancer stem cells through proteomic profiling
| Journal of Liver Cancer(대한간암학회지) |
| 2025 | Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
| CANCERS |
| 2025 | Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2025 | Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study"
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2025 | Is liver resection still required for patients who have predictive factors for complete pathologic necrosis after downstaging treatments of locally advanced hepatocellular carcinoma? | EJSO |
| 2024 | Incidence of metabolic dysfunction-associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
| LIVER CANCER |
| 2024 | Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study | FUTURE ONCOLOGY |
| 2024 | T-Cell Dynamics Predicts Prognosis of Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2024 | Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/ bevacizumab failure: A real-world study”
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agents | LIVER INTERNATIONAL |
| 2024 | Outcome of Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma: Glass Versus Resin Microsphere | CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY |
| 2024 | Regulation of Tumor Microenvironment through YAP/TAZ under Tumor Hypoxia
| CANCERS |
| 2024 | Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2024 | Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Liver-Directed Combined Radiation Therapy for Downstaging Beyond-Milan Hepatocellular Carcinoma to Liver Transplantation | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2024 | Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study | JOURNAL OF HEPATOLOGY |
| 2024 | Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2024 | Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories | JOURNAL OF HEPATOLOGY |
| 2024 | Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study
| NPJ DIGITAL MEDICINE(Nature partner journals digital medicine Digital medicine) |
| 2024 | Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
| GUT AND LIVER |
| 2024 | Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease | GUT AND LIVER |
| 2023 | Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study
| CANCERS |
| 2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B | LIVER INTERNATIONAL |
| 2023 | A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2023 | Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria
| CANCER RESEARCH AND TREATMENT |
| 2023 | The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
| CLINICAL AND MOLECULAR HEPATOLOGY |
(56119929100)
